Calm Logic
GLP-1 Specialist
New potential uses for popular peptides 🙂
MOTS-c:
SS-31:
link.springer.com
GHK-Cu:
"Just when I think I know everything that these peptides treat, some other benefit emerges"
~ @amynurse
MOTS-c:
The present study is the first to provide evidence that MOTS-c may be a promising therapeutic target for neuropathic pain.

Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review)
Mitochondria‑derived peptides (MDPs) are a unique class of peptides encoded by short open reading frames in mitochondrial DNA, including the mitochondrial open reading frame of the 12S ribosomal RNA type‑c (MOTS‑c). Recent studies suggest that MDPs offer therapeutic benefits in various diseases...
www.spandidos-publications.com
In a study in which vascular calcification was induced in rats through treatment with vitamin D3 and nicotine, subsequent treatment with MOTS-c markedly reduced blood pressure, preserved normal heart structure and decreased vascular stiffness. These findings demonstrate that MOTS-c can improve cardiovascular and vascular abnormalities caused by vascular calcification.
SS-31:
SS-31 markedly improved the behavioral indices and significantly mitigated the damage to the sciatic nerve

SS-31 alleviated nociceptive responses and restored mitochondrial function in a headache mouse model via Sirt3/Pgc-1α positive feedback loop - The Journal of Headache and Pain
Migraine is the second highest cause of disability worldwide, bringing a huge socioeconomic burden. Improving mitochondrial function has promise as an effective treatment strategy for migraine. Szeto-Schiller peptide (SS-31) is a new mitochondria-targeted tetrapeptide molecule that has been...

SS-31 has the potential to be an effective drug candidate for headache treatment.
SS-31, as a mitochondrial protectant, could improve mitochondrial function and promote the healing of tendinopathy.
Google Gemini said:Studies have indicated that SS-31 can improve mitochondrial function in tendon cells and promote the healing process in injured tendons.
GHK-Cu:
Research in animal models has indicated that GHK-Cu may protect diabetic rats from kidney-damaging fibrosis by increasing decorin, an anti-inflammatory proteoglycan.
The GHK-Cu peptide should be considered a promising neuroprotective agent capable of preventing the development of common age-associated neurodegenerative disorders.
"Just when I think I know everything that these peptides treat, some other benefit emerges"
~ @amynurse
Last edited: